Preceding endoscopic risk factors for the gastric neoplasm in the upper gastrointestinal endoscopy screening
Endoscopy · 01.04.2023 · 55 (S 02 S 02) · S62-S63
DOI: 10.1055/s-0043-1765151 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2023. Verfasst von J. Huh und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
There have been little data on the endoscopic characteristics before the diagnosis of gastric neoplasms in the biennial upper gastrointestinal endoscopy screening. We investigate the preceding endoscopic risk factors for the gastric neoplasm by analyzing the endoscopic and histologic findings prior to diagnosis of the gastric neoplasm in the serial endoscopy screening.
Methods
We performed a multicenter retrospective study, from January 2010 to July 2022 at a secondary hospital and from October 2005 to July 2013 at a tertiary hospital. We reviewed the upper gastrointestinal endoscopy in which gastric adenocarcinoma or adenoma were diagnosed, but gastric neoplasm had never been found in the previous endoscopy. We analyzed the preceding endoscopic findings, pathologic features and clinical characteristics.
Results
A total of 246 lesions with a histologic diagnosis of gastric epithelial neoplasms (95 adenomas, 151 adenocarcinoma) were identified. The mean interval between the two endoscopies was 825 days in adenoma, 940 days in adenocarcinoma, respectively. The initial endoscopic lesion findings were 14 normal (5.69%), 10 gastritis (4.06%), 45 erosion (18.29%), 18 ulcer (7.31%), 76 atrophy (30.89%), 80 intestinal metaplasia (32.52%) and 3 polyp (1.21%). Intestinal metaplasia is the leading endoscopic lesion finding in adenoma (n=38, 40.00%), but 2nd leading finding in adenocarcinoma (n=42, 27.81%) ([ Table 1 ]). Table 1 Multivariable analysis for stomach cancer detection.
Conclusions
In conclusion, over-one-year interval and findings as intestinal metaplasia and atrophy during upper gastrointestinal endoscopy screening should trigger precautious follow-up endoscopy. Publication History Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Huh, J., Kim, K. W., Jeong, Y. J., Oh, D. J., Jang, H., Jang, D. K., Kim, S. H., Kang, H. W., Kim, J. W., & Lee, K. L. (2023). Preceding endoscopic risk factors for the gastric neoplasm in the upper gastrointestinal endoscopy screening. Endoscopy, 55(S 02 S 02), S62-S63. https://doi.org/10.1055/s-0043-1765151
Vancouver
Huh J, Kim KW, Jeong YJ, Oh DJ, Jang H, Jang DK, et al. Preceding endoscopic risk factors for the gastric neoplasm in the upper gastrointestinal endoscopy screening. Endoscopy. 2023;55(S 02 S 02):S62-S63. doi:10.1055/s-0043-1765151
BibTeX
@article{Huh2023,
author = {Huh, J. and Kim, K. W. and Jeong, Y. J. and Oh, D. J. and Jang, H. and Jang, D. K. and Kim, S. H. and Kang, H. W. and Kim, J. W. and Lee, K. L.},
title = {Preceding endoscopic risk factors for the gastric neoplasm in the upper gastrointestinal endoscopy screening},
journal = {Endoscopy},
year = {2023},
volume = {55},
number = {S 02 S 02},
pages = {S62--S63},
doi = {10.1055/s-0043-1765151}
}
EUVIMED